Market
Story
Surgeons Complete Fifth Gene-Edited Pig Organ Transplant for Alabama Woman with FDA's Permission
Dec 22, 2024, 01:11 PM
Scientists are advancing the field of organ transplantation by raising pigs with genetically modified organs for potential use in humans, with the endorsement of the FDA. Recently, surgeons completed the fifth successful gene-edited pig organ transplant for a woman in Alabama. This development highlights the ongoing research into xenotransplantation, particularly as the latest recipient of a pig kidney was noted to be a patient who may not have been critically ill enough to qualify for a human donor. This situation could contribute to further advancements in the field, as it underscores the potential of genetically modified organs in addressing organ shortages.
View original story
Similar markets
Good health, minor complications • 25%
Excellent health, no complications • 25%
Serious health decline • 25%
Health issues, major complications • 25%
Fully recovered • 25%
Minor complications • 25%
Major complications • 25%
Deceased • 25%
No • 50%
Yes • 50%
Minor complications managed • 25%
Significant complications • 25%
Transplant rejection • 25%
Fully functional without issues • 25%
Functioning with minor complications • 25%
Functioning without complications • 25%
Other significant outcome • 25%
Rejection • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Less than 1 month • 25%
6 to 12 months • 25%
1 to 6 months • 25%
More than 12 months • 25%
Stable with minor issues • 25%
Fully recovered • 25%
Experiencing major complications • 25%
Deceased • 25%